Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat VEGFC ELISA Kit (AC3515)
Cat.#: ASET-2104
Specifications
Description Rat VEGFC ELISA Kit allows for the in vitro quantitative determination of rat VEGFC concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.688 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 7.813-500 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1870 Human Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3281) Quantitative inquiry ASET-2244 Human Big Dynorphin ELISA Kit (AC3655) Quantitative inquiry ASET-2140 Rat Laminin ELISA Kit (AC3551) Quantitative inquiry ASET-2120 Rat ARNT2 ELISA Kit (AC3531) Quantitative inquiry ASET-1206 Human Substance P ELISA Kit (AC2617) Quantitative inquiry ASET-1395 Rat Glucose 6 Phosphate Isomerase ELISA Kit (AC2806) Quantitative inquiry ASET-1472 Human MEF2A ELISA Kit (AC2883) Quantitative inquiry ASET-1087 Rat Dystrophin ELISA Kit (AC2498) Quantitative inquiry ASET-2095 Rat Dopamine D2 Receptor ELISA Kit (AC3506) Quantitative inquiry ASET-1718 Mouse CDNF ELISA Kit (AC3129) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket